Survival after proton-beam irradiation of uveal melanomas

American Journal of Ophthalmology

Volumn 137, Issue 6, 2004, Pages 1002-1010

  Kodjikian, L ^a   Roy, P ^b   Rouberol, F ^b   Garweg, J G ^b   Chauvel, P ^b   Manon, L ^b   Jean Louis, B ^b   Little, R E ^b   Sasco, A J ^b   Grange, J D ^b  

^a CROIX ROUSSE HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BEAM THERAPY; CALCULATION; CANCER RECURRENCE; CANCER SURVIVAL; CILIARY BODY; CONTROLLED STUDY; ENUCLEATION; EVALUATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; DISEASE-FREE SURVIVAL; EYE ENUCLEATION; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, HIGH-ENERGY; RETROSPECTIVE STUDIES; SEX FACTORS; SURVIVAL RATE; UVEAL NEOPLASMS;

EID: 2942588706     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.01.006     Document Type: Article

References (49)

1. Shields J., Shields C. Intraocular tumors a text and atlas. 1992;WB Saunders, Philadelphia
2. Shields J.A., Shields C.L. Current management of posterior uveal melanoma. Mayo Clin Proc. 68:1993;1196-1200
3. Gragoudas E.S., Goitein M., Koehler A.M., et al. Proton irradiation of small choroidal malignant melanomas. Am J Ophthalmol. 83:1977;665-673
4. Seddon J.M., Gragoudas E.S., Albert D.M., et al. Comparison of survival rates for patients with uveal melanoma after treatment with proton beam irradiation or enucleation. Am J Ophthalmol. 99:1985;282-290
5. De Potter P., Shields C.L., Shields J.A., Cater J.R., Tardio D.J. Impact of enucleation versus plaque radiotherapy in the management of juxtapapillary choroidal melanoma on patient survival. Br J Ophthalmol. 78:1994;109-114
6. Augsburger J.J., Correa Z.M., Freire J., Brady L.W. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy. Ophthalmology. 105:1998;1670-1678
7. Adams K.S., Abramson D.H., Ellsworth R.M., et al. Cobalt plaque versus enucleation for uveal melanoma comparison of survival rates. Br J Ophthalmol. 72:1988;494-497
8. Lommatzsch P.K. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas 20 years' experience. Br J Ophthalmol. 70:1986;844-851
9. Char D.H., Castro J.R., Quivey J.M., et al. Uveal melanoma radiation. 125I brachytherapy versus helium ion irradiation. Ophthalmology. 96:1989;1708-1715
10. Diener-West M., Earle J.D., Fine S.L., et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. II characteristics of patients enrolled and not enrolled. COMS report no 17. Arch Ophthalmol. 119:2001;951-965
11. Diener-West M., Earle J.D., Fine S.L., et al. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma. III initial mortality findings. COMS report no 18. Arch Ophthalmol. 119:2001;969-982
12. Hermanek P., Sobin L. Union Internationale Contre le Cancer. TNM classification of malignant tumours. [translation]:1988;Springer-Verlag, Geneva
13. Collaborative Ocular Melanoma Study Group. Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS) COMS report no. 15. Arch Ophthalmol. 119:2001;670-676
14. Melia B.M., Abramson D.H., Albert D.M., et al. Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years. COMS report no 16. Ophthalmology. 108:2001;348-366
15. Collaborative Ocular Melanoma Study Group. Factors predictive of growth and treatment of small choroidal melanoma COMS report no. 5. The Collaborative Ocular Melanoma Study Group. Arch Ophthalmol. 115:1997;1537-1544
16. Eskelin S., Pyrhonen S., Summanen P., Prause J.U., Kivela T. Screening for metastatic malignant melanoma of the uvea revisited. Cancer. 85:1999;1151-1159
17. Kaplan E., Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc. 53:1958;457-481
18. Cox D. Regression models and life-tables (with discussions). J Roy Statist Soc Series B. 34:1972;187-220
19. Krengli M., Munzenrider J., Suit H. Clinical experience with proton beam therapy at MGH, MEEI, and HCL skull base sarcoma and uveal melanoma. Amaldi U., Larsson B., Lemoigne Y. Advances in hadrontherapy. 1997;95-102 Elsevier, Amsterdam
20. Egger E., Zografos L. Proton beam irradiation of uveal melanoma at PSI latest results. Amaldi U., Larsson B. Hadrontherapy in oncology. 1994;145-149 Elsevier, Amsterdam
21. Fuss M., Loredo L.N., Blacharski P.A., Grove R.I., Slater J.D. Proton radiation therapy for medium and large choroidal melanoma preservation of the eye and its functionality. Int J Radiat Oncol Biol Phys. 49:2001;1053-1059
22. Lommatzsch P.K., Werschnik C., Schuster E. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol. 238:2000;129-137
23. Grange J., Joschi G., Gerard J., et al. Results of 10 years' experience with contact beta-therapy with Ruthénium 106 applicators for uveal melanoma. Review of 207 cases and tribute to PK Lommatzsch. [translation] Ophtalmologie. 9:1995;317-323
24. Diener-West M., Hawkins B.S., Markowitz J.A., Schachat A.P. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol. 110:1992;245-250
25. Gragoudas E.S., Seddon J.M., Egan K.M., et al. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology. 95:1988;992-999
26. Seddon J.M., Albert D.M., Lavin P.T., Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 101:1983;1894-1899
27. Kroll S., Char D.H., Quivey J., Castro J. A comparison of cause-specific melanoma mortality and all-cause mortality in survival analyses after radiation treatment for uveal melanoma. Ophthalmology. 105:1998;2035-2045
28. Gragoudas E.S., Seddon J.M., Egan K.M., et al. Prognostic factors for metastasis following proton beam irradiation of uveal melanomas. Ophthalmology. 93:1986;675-680
29. Raivio I. Uveal melanoma in Finland. An epidemiological, clinical, histological and prognostic study. Acta Ophthalmol. 133:(Suppl):1977;1-64
30. Li W., Gragoudas E.S., Egan K.M. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma. Arch Ophthalmol. 118:2000;1066-1070
31. Sisley K., Rennie I.G., Parsons M.A., et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer. 19:1997;22-28
32. Prescher G., Bornfeld N., Hirche H., et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 347:1996;1222-1225
33. Egger E., Schalenbourg A., Zografos L., et al. Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys. 51:2001;138-147
34. Gragoudas E.S., Egan K.M., Seddon J.M., Walsh S.M., Munzenrider J.E. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology. 99:1992;760-766
35. Bacin F., Kwiatkowski F., Dalens H., et al. Long-term results of cobalt 60 curietherapy for uveal melanoma. [translation] J Fr Ophtalmol. 21:1998;333-344
36. Karlsson U.L., Augsburger J.J., Shields J.A., et al. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy. Ophthalmology. 96:1989;382-388
37. Summanen P., Immonen I., Heikkonen J., et al. Survival of patients and metastatic and local recurrent tumor growth in malignant melanoma of the uvea after ruthenium plaque radiotherapy. Ophthalmic Surg. 24:1993;82-90
38. Foerster M.H., Bornfeld N., Schulz U., Wessing A., Meyer-Schwickerath G. Complications of local beta radiation of uveal melanomas. Graefes Arch Clin Exp Ophthalmol. 224:1986;336-340
39. Wilson M.W., Hungerford J.L. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology. 106:1999;1579-1587
40. Packer S., Stoller S., Lesser M.L., Mandel F.S., Finger P.T. Long-term results of iodine 125 irradiation of uveal melanoma. Ophthalmology. 99:1992;767-774
41. Fontanesi J., Meyer D., Xu S., Tai D. Treatment of choroidal melanoma with I-125 plaque. Int J Radiat Oncol Biol Phys. 26:1993;619-623
42. Harbour J.W., Char D.H., Kroll S., Quivey J.M., Castro J. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma. Ophthalmology. 104:1997;1785-1793
43. Gragoudas E.S., Li W., Goitein M., et al. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol. 120:2002;1665-1671
44. Gragoudas E.S., Lane A.M., Munzenrider J., Egan K.M., Li W. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc. 100:2002;43-48
45. Egan K.M., Ryan L.M., Gragoudas E.S. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma an example of regression on time-dependent covariates. Arch Ophthalmol. 116:1998;366-370
46. Char D.H., Kroll S.M., Castro J. Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol. 125:1998;81-89
47. Summanen P., Immonen I., Kivela T., et al. Radiation related complications after ruthenium plaque radiotherapy of uveal melanoma. Br J Ophthalmol. 80:1996;732-739
48. Seregard S., aft Trampe E., Lax I., Kock E., Lundell G. Results following episcleral ruthenium plaque radiotherapy for posterior uveal melanoma. The Swedish experience. Acta Ophthalmol Scand. 75:1997;11-16
49. Egan K.M., Gragoudas E.S., Seddon J.M., et al. The risk of enucleation after proton beam irradiation of uveal melanoma. Ophthalmology. 96:1989;1377-1383